Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 5.05 % |
3 Month Return | + 13.82 % |
1 Year Return | + 33.96 % |
Market Stats | |
Previous Close | ₹157.40 |
Open | ₹151.80 |
Volume | 1.20L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹561.76Cr |
P/E Ratio | -67.84 |
PEG Ratio | -21.96 |
Market Cap | ₹561.76 Cr |
P/B Ratio | 3.88 |
EPS | -0.79 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹561.76 Cr | 128.49% | 0.69 | -₹3 Cr | ₹111 Cr | |
BUY | ₹12,423.88 Cr | -3.8% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
NA | ₹1,067.07 Cr | -1.52% | 0.56 | ₹41 Cr | ₹338 Cr | |
NA | ₹3,528.84 Cr | 766.04% | 0.51 | NA | NA | |
NA | ₹21,764.79 Cr | 84.32% | 0.77 | -₹472 Cr | ₹2,798 Cr |
Organisation | Lyka Labs |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Lyka Labs Ltd
Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 13 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -2.13 Cr → 2.1 Cr (in ₹), with an average increase of 139.7% per quarter
Price Rise
In the last 6 months, LYKALABS stock has moved up by 35.3%
Revenue Rich
Revenue is up for the last 3 quarters, 28.08 Cr → 41.18 Cr (in ₹), with an average increase of 17.0% per quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 139.0%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 41.08% of holdings in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 24.1%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.15% of holdings in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 58.10% of holdings in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 58.1% | 0.00 | |
Foreign Institutions | 0.15% | 0.13 | |
Mutual Funds | 0.01% | 0.00 | |
Retail Investors | 41.08% | 0.00 | |
Others | 0.66% | 0.00 |
Lyka Labs in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (-67.84x)
January 21, 2025
Industry (55.69x)
January 21, 2025
Highest (23.04x)
September 5, 2022
Lyka Labs Ltd’s net profit jumped 528.57% since last year same period to ₹2.10Cr in the Q2 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 45.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Lyka Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Lyka Labs Ltd share price today stands at ₹151.8, Open. ₹151.8 ; Previous Close. ₹157.4 ; High. ₹158.93 ; Low. ₹151.65 ; 52 Week High. ₹176.59 ; 52 Week Low: ₹97.9.
Lyka Labs Ltd is listed on NSE
Lyka Labs Ltd is listed on BSE
PE Ratio of Lyka Labs Ltd is -67.84
PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share
Today’s traded volume of Lyka Labs Ltd(LYKALABS) is 1.20L.
Today’s market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹561.76Cr.
Lyka Labs Ltd(LYKALABS | Price |
---|---|
52 Week High | ₹176.59 |
52 Week Low | ₹97.9 |
Lyka Labs Ltd(LYKALABS) share price is ₹151.8. It is down -14.04% from its 52 Week High price of ₹176.59
Lyka Labs Ltd(LYKALABS) share price is ₹151.8. It is up 55.06% from its 52 Week Low price of ₹97.9
Lyka Labs Ltd(LYKALABS | Returns |
---|---|
1 Day Returns | -5.6% |
1 Month Returns | 5.05% |
3 Month Returns | 13.82% |
1 Year Returns | 33.96% |